REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT06975787 updates: 1. completion date: 2029-09-09 → 2029-09-10 2. primary completion date: 2029-09-09 → 2029-09-10
Clinical trial NCT06975787 updates: 1. completion date: 2029-09-09 → 2029-09-10 2. primary completion date: 2029-09-09 → 2029-09-10
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical